Cancer News and Research

Latest Cancer News and Research

Bone marrow stem cells offer potential treatment for patients with peripheral arterial disease

Bone marrow stem cells suspended in X-ray-visible microbubbles dramatically improve the body's ability to build new blood vessels in the upper leg-providing a potential future treatment for those with peripheral arterial disease or PAD, say researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

18 Mar 2010

Standardized skin-care guidelines

Given the complexity of cancer treatment, skin care may seem like a small matter. However, a nurse at the James P. Wilmot Cancer Center knew that skin issues were a constant source of anxiety for many patients receiving radiation therapy, and through research she discovered that routine advice was rooted in myth instead of scientific evidence.

18 Mar 2010

LSUHSC: Differences in drug metabolism can lead to differences in the effectiveness of candidate drug

Research led by Wayne L. Backes, PhD, Professor of Pharmacology and Associate Dean for Research at LSU Health Sciences Center New Orleans School of Medicine, has found that drug metabolism depends not only upon which enzymes are present in an individual, but also how they interact, and that can be the difference in whether a drug is safely eliminated from the body or is converted into a toxic or carcinogenic byproduct.

18 Mar 2010

Early baldness may not be associated with risk of prostate cancer

Men who start losing their hair at an early age may be less likely to develop prostate cancer in the future, new research suggests.

18 Mar 2010

SBRT can improve survival rates for patients with inoperable non-small cell lung cancer

Highly-focused stereotactic body radiation therapy (SBRT) can eliminate the targeted tumor while avoiding treatment-related illness and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to early findings of a Radiation Therapy Oncology Group study published in the March 17 cancer-themed issue of the Journal of the American Medical Association.

18 Mar 2010

iVillage launches new Health site to help women manage their health needs online

iVillage today announced the launch of its new Health site (www.ivillage.com/Health), the first women's destination on the Web that combines medical expertise and original health content with community conversations and interactive tools, to help women manage their health needs online.

18 Mar 2010

Adjuvant chemotherapy may benefit older patients with stage III colon cancer

Even though older patients with colon cancer are less likely to receive chemotherapy following surgery because of concerns of adverse events, new research indicates that when they do receive this treatment, it is less toxic and of shorter duration than therapy younger patients receive, and older patients experience fewer adverse events, according to a study in the March 17 issue of JAMA, a theme issue on cancer.

18 Mar 2010

Berkeley HeartLab adopts GenTegra DNA to support diagnostic genetic testing for cardiovascular disease

GenVault Corporation today announced that Berkeley HeartLab, a subsidiary of Celera Corporation, has adopted GenTegra DNA to preserve and store diagnostic samples for genetic testing related to the management of cardiovascular disease.

18 Mar 2010

McGill researchers pioneer major breakthrough in DNA nanotechnology

A team of McGill Chemistry Department researchers led by Dr. Hanadi Sleiman has achieved a major breakthrough in the development of nanotubes - tiny "magic bullets" that could one day deliver drugs to specific diseased cells.

18 Mar 2010

Virtuoso Digital Pathology Software: BioImagene adds Companion Algorithms for colon cancer

BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, today announced the availability of Companion Algorithms™ for colon cancer in their Virtuoso™ Digital Pathology Software. BioImagene’s Companion Algorithms are unique in the digital pathology industry as they are specific to a biomarker and a tissue type. Therefore, pathologists are not faced with the challenges of customizing generic algorithms in order to make them work.

18 Mar 2010

Harbor BioSciences receives approval for stock listing transfer to The Nasdaq Capital Market

Harbor BioSciences, Inc. today announced that NASDAQ has approved its application to transfer its stock listing to The Nasdaq Capital Market from The Nasdaq Global Market, effective at the opening of business on March 18, 2010. The company's common stock will continue to be traded under the symbol "HRBR." The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as the Nasdaq Global Market.

18 Mar 2010

Watchful waiting is viable option for many men with low risk prostate cancer

Active surveillance, also referred to as watchful waiting, is a viable option for many men with low risk prostate cancer although the concept continues to cause distress and confusion. James L. Mohler, MD, of Roswell Park Cancer Institute and chair of the NCCN Guidelines Panel for Prostate Cancer, discussed the role of active surveillance as well as other treatment options recommended in the recently updated NCCN Guidelines™ for Prostate Cancer at the NCCN 15th Annual Conference.

18 Mar 2010

Cryotherapy may become the future treatment for cancer

Cryotherapy, an interventional radiology treatment to freeze cancer tumors, may become the treatment of the future for cancer that has metastasized in soft tissues (such as ovarian cancer) and in bone tumors.

18 Mar 2010

SBRT doubles rate of primary tumor control compared to conventional radiotherapy

Early findings suggest a radiation therapy that involves numerous highly-focused and potent radiation beams provides targeted tumor control in nearly all patients, reduces treatment-related illness, and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to a study in the March 17 issue of JAMA, a theme issue on cancer.

18 Mar 2010

New specialty service at Montefiore Medical Center helps patients with drug allergies

A Westchester patient takes aspirin for pain, but develops rashes and hives. A Bronx patient with a gastrointestinal problem caused by bacteria is prescribed penicillin, then passes out. A Bronx woman is given a contrast dye for an internal diagnostic exam, then her skin peels off.

18 Mar 2010

Genes linked to ulcerative colitis identified

A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease.

18 Mar 2010

NICE leaves many patients with rarer forms of cancer without drugs

The National Institute for Health and Clinical Excellence (NICE) is failing to follow its own guidance aimed at making live-extending treatments available on the NHS, leaving many patients with rarer forms of cancer without drugs that could prolong their lives, a campaign group has said.

18 Mar 2010

Purified form of omega 3 curbs precancerous bowel polyps

A purified form of an omega 3 cuts the number and size of precancerous bowel growths (polyps) in people whose genetic make-up predisposes them to bowel cancer, finds research published ahead of print in the journal Gut.

18 Mar 2010

Micromet announces the closing of previously announced underwritten public offering

Micromet, Inc. announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised in full their option to purchase an additional 1.5 million shares of common stock. As a result, Micromet sold a total of 11.5 million shares of its common stock at a public offering price of $7.00 per share.

18 Mar 2010

Research shows Caspase-1 protein plays a key role in the process of inflammation and colon cancer

Every day, our gut comes in contact with bacteria, inducing an inflammatory response that is tolerated and controlled. Sometimes the control of inflammation is lost and this can lead to inflammatory bowel disease that may predispose to colon cancer.

18 Mar 2010

Cancer News and Research

Latest Cancer News and Research

Bone marrow stem cells offer potential treatment for patients with peripheral arterial disease

Standardized skin-care guidelines

LSUHSC: Differences in drug metabolism can lead to differences in the effectiveness of candidate drug

Early baldness may not be associated with risk of prostate cancer

SBRT can improve survival rates for patients with inoperable non-small cell lung cancer

iVillage launches new Health site to help women manage their health needs online

Adjuvant chemotherapy may benefit older patients with stage III colon cancer

Berkeley HeartLab adopts GenTegra DNA to support diagnostic genetic testing for cardiovascular disease

McGill researchers pioneer major breakthrough in DNA nanotechnology

Virtuoso Digital Pathology Software: BioImagene adds Companion Algorithms for colon cancer

Harbor BioSciences receives approval for stock listing transfer to The Nasdaq Capital Market

Watchful waiting is viable option for many men with low risk prostate cancer

Cryotherapy may become the future treatment for cancer

SBRT doubles rate of primary tumor control compared to conventional radiotherapy

New specialty service at Montefiore Medical Center helps patients with drug allergies

Genes linked to ulcerative colitis identified

NICE leaves many patients with rarer forms of cancer without drugs

Purified form of omega 3 curbs precancerous bowel polyps

Micromet announces the closing of previously announced underwritten public offering

Research shows Caspase-1 protein plays a key role in the process of inflammation and colon cancer

Industry Focus eBook - Oncology (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in